Multiple Sclerosis Trial, By Invitation NCT07567989 Sponsor: Jacobo Formigo Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, By Invitation

NCT07567989
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have given their written agreement to participate in the study.
  • People who have a confirmed diagnosis of multiple sclerosis.
  • People who experience fatigue related to multiple sclerosis, measured at a level of 4 or above on a fatigue rating scale.
  • People who have enough physical ability to complete a six-minute walking test, based on a movement and walking ability score of 3 or higher.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who had a neurological, rheumatological, or other medical condition before their multiple sclerosis diagnosis that could affect study results.
  • People who have medical reasons that make a type of brain stimulation treatment (called tDCS) unsafe for them, such as having a pacemaker, a history of epilepsy, being pregnant, or having implanted brain electrodes, a defibrillator, or similar electronic devices.
  • People whose level of cognitive (thinking and memory) difficulty makes it hard for them to take part in study procedures.
  • People who have had changes to their physical therapy or medication for multiple sclerosis and/or fatigue that are not part of the study plan.
  • People who experience a multiple sclerosis relapse or a worsening of their condition that affects their functioning during the study period.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Jacobo Formigo
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
31 August 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Change in Fatigue Severity Measured by the Fatigue Severity Scale (FSS); Change in Fatigue Severity Measured by Visual Analogue Scale (VAS) for Fatigue

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov